Response of Gut Microbiota in Type 2 Diabetes to Hypoglycemic Agents

NCT04287387 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

180

Enrollment

OTHER

Sponsor class

Conditions

Type2 Diabetes Mellitus

Interventions

DRUG: Glucophage 500Mg Tablet
DRUG: Acarbose Tablets
DRUG: Sitagliptin tablet
DRUG: Dapagliflozin Tablet
DRUG: Pioglitazone Tablets
DRUG: Glimepiride Tablets

Sponsor

Peking Union Medical College Hospital

Collaborators

[object Object]